The time to offer treatments for COVID-19
Autor:
Ngo, Binh T.
; Marik, Paul
; Kory, Pierre
; Shapiro, Leland
; Thomadsen, Raphael
; Iglesias, Jose
; Ditmore, Stephen
; Rendell, Marc
; Varon, Joseph
; Dube, Michael
; Nanda, Neha
; In, Gino K.
; Arkfeld, Daniel
; Chaudhary, Preet
; Campese, Vito M.
; Hanna, Diana L.
; Sawcer, David E.
; Ehresmann, Glenn
; Peng, David
; Smorgorzewski, Miroslaw
; Armstrong, April
; Dasgupta, Rajkumar
; Sattler, Fred R.
; Brennan-Rieder, Denise
; Mussini, Cristina
; Mitjà, Oriol
; Soriano, Vicente
; Peschanski, Nicolas
; Hayem, Gilles
; Confalonieri, Marco
; Piccirillo, Maria Carmela
; Lobo-Ferreira, António
; Bello Rivero, Iraldo
; Turkia, Mika
; Vinjevoll, Eivind H.
; Griffin, Daniel O.
; Hung, Ivan Fn
Fecha:
2021Palabra clave:
Revista / editorial:
Expert opinion on investigational drugsTipo de Ítem:
articleResumen:
Background: COVID-19 has several overlapping phases. Treatments to date have focused on the late stage of disease in hospital. Yet, the pandemic is by propagated by the viral phase in out-patients. The current public health strategy relies solely on vaccines to prevent disease.Methods: We searched the major national registries, pubmed.org, and the preprint servers for all ongoing, completed and published trial results.Results: As of 2/15/2021, we found 111 publications reporting findings on 14 classes of agents, and 9 vaccines. There were 62 randomized controlled studies, the rest retrospective observational analyses. Only 21 publications dealt with outpatient care. Remdesivir and high titer convalescent plasma have emergency use authorization for hospitalized patients in the U.S.A. There is also support for glucocorticoid treatment of the COVID-19 respiratory distress syndrome. Monoclonal antibodies are authorized for outpatients, but supply is inadequate to treat all at time of diagnosis. Favipiravir, ivermectin, and interferons are approved in certain countries.Expert Opinion: Vaccines and antibodies are highly antigen specific, and new SARS-Cov-2 variants are appearing. We call on public health authorities to authorize treatments with known low-risk and possible benefit for outpatients in parallel with universal vaccination.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
16 |
111 |
97 |
20 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials
Griffin, Daniel O.; Brennan-Rieder, Denise; Ngo, Binh; Kory, Pierre; Confalonieri, Marco; Shapiro, Leland; Iglesias, Jose; Dube, Michael; Nanda, Neha; In, Gino K.; Arkfeld, Daniel; Chaudhary, Preet; Campese, Vito M.; Hanna, Diana L.; Sawcer, David; Ehresmann, Glenn; Peng, David; Smorgorzewski, Miroslaw; Amstrong, April; Vinjevoll, Eivind H.; Dasgupta, Rajkumar; Sattler, Fred R.; Mussini, Cristina; Mitjà, Oriol; Soriano, Vicente ; Peschanski, Nicolas; Hayem, Gilles; Piccirillo, Maria Carmela; Lobo-Ferreira, António; B. Rivero, Iraldo; Hung, Ivan F. H.; Rendell, Marc; Ditmore, Stephen; Varon, Joseph; Marik, Paul (AIDS reviews, 2021)COVID-19, caused by SARS-CoV-2, continues to be a major health problem since its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to date in the treatment of COVID-19. Critical to treatment ... -
The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study
Ferraro, Laura; La Cascia, Caterina; La Barbera, Daniele; Sánchez-Gutiérrez, Teresa ; Tripoli, Giada; Seminerio, Fabio; Sartorio, Crocettarachele; Sideli, Lucia; Arango, Celso; Arrojo, Manuel; Bernardo, Miguel; Bobes, Julio; Del-Ben, Cristina Marta; Gayer-Anderson, Charlotte; Jongsma, Hannah E.; Kirkbride, James B.; Lasalvia, Antonio; Tosato, Sarah; Llorca, Pierre-Michel; Menezes, Paulo Rossi; Rutten, Bart P.; Santos, Jose Luis; Sanjuán, Julio; Selten, Jean-Paul; Szöke, Andrei; Tarricone, Ilaria; Muratori, Roberto; Tortelli, Andrea; Velthorst, Eva; Rodriguez, Victoria; Quattrone, Andrea; Jones, Peter B.; Van Os, Jim; Vassos, Evangelos; Morgan, Craig; de Haan, Lieuwe; Reininghaus, Ulrich; Cardno, Alastair G.; Di Forti, Marta; Murray, Robin M.; Quattrone, Diego (Elsevier B.V., 2021)Premorbid functioning and cognitive measures may reflect gradients of developmental impairment across diagnostic categories in psychosis. In this study, we sought to examine the associations of current cognition and premorbid ... -
Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study
Baenas, Isabel; Etxandi, Mikel; Munguía, Lucero; Granero, Roser; Mestre-Bach, Gemma ; Sánchez, Isabel; Ortega, Emilio; Andreu, Alba; Moize, Violeta L.; Fernández-Real, Jose-Manuel; Tinahones, Francisco J.; Diéguez, Carlos; Frühbeck, Gema; Le Grange, Daniel; Tchanturia, Kate; Karwautz, Andreas; Zeiler, Michael; Imgart, Hartmut; Zanko, Annika; Favaro, Ángela; Claes, Laurence; Shekriladze, Ia; Serrano‐Troncoso, Eduardo; Cecilia-Costa, Raquel; Rangil, Teresa; Loran Meler, Maria Eulalia; Soriano‐Pacheco, José; Carceller‐Sindreu, Mar; Navarrete, Rosa; Lozano, Meritxell; Linares, Raquel; Gudiol, Carlota; Carratala, Jordi; Plana, María T.; Graell, Montserrat; González-Parra, David; Gómez-del Barrio, José A.; Sepúlveda, Ana R.; Sánchez-González, Jéssica; Machado, Paulo PP; Håkansson, Anders; Túry, Ferenc; Pászthy, Bea; Stein, Daniel; Papezová, Hana; Gricova, Jana; Bax, Brigita; Borisenkov, Mikhail F.; Popov, Sergey V.; Gubin, Denis G.; Petrov, Ivan M.; Isakova, Dilara; Mustafina, Svetlana V.; Kim, Youl‐Ri; Nakazato, Michiko; Godart, Nathalie; van Voren, Robert; Ilnytska, Tetiana; Chen, Jue; Rowlands, Katie; Voderholzer, Ulrich; Monteleone, Alessio M.; Treasure, Janet; Jiménez-Murcia, Susana; Fernández-Aranda, Fernando (Nutrients, 01/2022)Background. The COVID-19 lockdown has had a significant impact on mental health. Patients with eating disorders (ED) have been particularly vulnerable. Aims. (1) To explore changes in eating-related symptoms and general ...